Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 + CHOP in Newly Diagnosed Peripheral T-cell Lymphomas
NCT01198665Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jul 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in peripheral T-cell lymphoma (PTCL), sponsored by Samsung Medical Center. Started Jul 2010; status: completed.
02
Drugs
everolimus
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01198665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198665.